Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy
Clinical trial NCT06680622 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06680622
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2027-09-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.